Fig. 2From: Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinomaPrognostic value of SR-BI expression in ccRCC patients. a Kaplan–Meier analysis indicated that patients with tumors that expressed high levels of SR-BI had a shorter PFS. b Mann–Whitney test showed that patients with tumors that expressed high SR-BI levels had a stronger potential of distant metastasis. **P < 0.01Back to article page